Cota, Genomic Testing Cooperative Ink Precision Oncology Partnership
The firms will combine real-world patient outcomes and clinical information with DNA and RNA sequencing data to help researchers advance personalized treatment approaches.
The privately held company is coupling gene expression tests with analysis to produce clinical decision support as it expands beyond its historic focus on pharma.
The company is hoping to gain a local coverage determination from CMS this year as it solidifies data for its first assay and works on building out a larger menu.
Viome Raises $54M to Advance mRNA Platform for Diagnosis, Drug Development
The funding is earmarked to support Viome's advancement of its mRNA platform in early disease diagnosis and therapy development.
Adaptive Biotechnologies Q3 Revenues Rise 50 Percent
The growth was primarily attributable to a near doubling of sequencing revenues, though development revenues also increased year over year.